The digital health IPO market has seen limited activity since a 2021 surge, with only a few companies like Tempus AI seeking public offerings. Many previous IPOs struggled, exemplified by Accolade's acquisition by Transcarent and Teladoc Health's significant losses. Recently, Hinge Health has filed for an IPO amidst this uncertainty, benefitting from its high valuation and market address. Investors, while cautiously optimistic about Hinge's potential, are wary of the sector’s regulatory challenges and the implications of another possible failure in digital health IPOs.
I was really excited to see that finally, the dam was breaking... You just don't want it to go out and be unsuccessful and then have people say, 'See, yet another digital health IPO kind of broke.' But I think they have a high quality asset here.
The financial profile of the company is interesting with high margins and high growth, not to mention that Hinge is addressing a massive market.
Since 2021, only a smidgen of companies have filed for IPO, showing the cautious atmosphere lingering in the digital health sector.
Accolade, which went public in 2020, is being acquired for $621 million, indicating the turbulent nature of digital health IPOs.
Collection
[
|
...
]